Related Experiment Video
Updated: Sep 23, 2025
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
394
The Correlation Between Platelet Count and Survival in Prostate Cancer
Tünde Mezei1, Imre Bőde1, Péter Tenke1
1Department of Urology, Jahn Ferenc South-Pest Hospital, Budapest, Hungary.
Research and Reports in Urology
|May 16, 2022
Summary
This study found no link between high platelet counts and survival outcomes in prostate cancer patients. Other factors like PSA levels and surgical margin status were more significant predictors of prognosis.
Area of Science:
- Oncology
- Hematology
Background:
- Elevated platelet count (thrombocytosis) is linked to poorer survival in many solid tumors.
- Limited data exists on thrombocytosis and survival specifically in prostate cancer.
Purpose of the Study:
- To investigate the association between thrombocytosis and survival in prostate cancer patients.
- To identify predictors of prognosis after prostatectomy.
Main Methods:
- Retrospective analysis of 316 prostate cancer patients post-laparoscopic prostatectomy.
- Evaluation of platelet count, PSA, TNM stage, hemoglobin, and surgical margin.
- Multivariate Cox proportional hazard model used for survival analysis.
Main Results:
- Thrombocytosis was rare (1/316 patients).
- Preoperative PSA, risk group, hemoglobin, and surgical margin predicted biochemical progression-free survival.
- Thrombocytosis and age at diagnosis did not predict survival.
Conclusions:
- No association was found between elevated platelet count and worse survival in this prostate cancer cohort.
- Prognostic value of thrombocytosis in prostate cancer remains uncertain based on this study.
More Related Videos
Related Concept Videos
01:21Cancer Survival Analysis
470
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
470
01:20Comparing the Survival Analysis of Two or More Groups
308
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
308